Lindberg, Søren Østergaard
Novo Nordisk (Denmark)
2 papers on CoChatORCID 0000-0002-9283-3979
Most cited papers
- Verified
Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial
Rodbard, H. W., Rosenstock, J., Canani, L. H., Deerochanawong, C., Gumprecht, J., Lindberg, S. Ø., Lingvay, I., Søndergaard, A. L., Treppendahl, M. B., Montanya, E., et al. (2019) · Diabetes Care
Diabetes Treatment and ManagementPharmacology and Obesity Treatment
Cited by 463
- Verified
Adiponectin, type 2 diabetes and cardiovascular risk
Lindberg, S., Jensen, J. S., Bjerre, M., Pedersen, S. H., Frystyk, J., Flyvbjerg, A., Galatius, S., Jeppesen, J., & Mogelvang, R. (2015) · European Journal of Preventive Cardiology
Adipokines, Inflammation, and Metabolic DiseasesCardiovascular Disease and Adiposity
Cited by 66
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free